Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context-Reference-Cited by-同舟云学术

Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context

Published:2019-06-13 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Patkar Nikhil,Kakirde Chinmayee,Bhanshe Prasanna,Joshi Swapnali,Chaudhary Shruti,Badrinath Yajamanam,Ghoghale Sitaram,Deshpande Nilesh,Kadechkar Shraddha,Chatterjee Gaurav,Kannan Sadhana,Shetty Dhanalaxmi,Gokarn Anant,Punatkar Sachin,Bonda Avinash,Nayak Lingaraj,Jain Hasmukh,Bagal Bhausaheb,Menon Hari,Sengar Manju,Khizer Syed Hasan,Khattry Navin,Tembhare Prashant,Gujral Sumeet,Subramanian Papagudi

Funder

DBT India Alliance

Lady Tata Memorial Trust

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference45 articles.

1. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials;Grimwade;Blood.,2010

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood.,2017

3. Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value;Abbas;Blood.,2010

4. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication;Paschka;J Clin Oncol.,2010

5. TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics;Chou;Blood.,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions;Biomedicines;2024-03-07

2. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1;Pediatric Blood & Cancer;2023-11-28

3. Molecular MRD Assessment in Acute Myeloid Leukemias;Indian Journal of Medical and Paediatric Oncology;2023-04-17

4. Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review;Cancers;2023-02-21

5. Flow cytometric measurable residual disease in adult acute myeloid leukemia: a preliminary report from Eastern India;Journal of Hematopathology;2023-01-10